A phase 1 study to evaluate the safety and tolerability of immunotherapy combinations in participants with advanced malignancies [AB928CSP0005].

  • Richardson, Gary (Primary Chief Investigator (PCI))
  • Baker, Emma (Project Manager)

Project: Research

StatusActive
Effective start/end date28/02/1931/12/24

Keywords

  • Medical Oncology
  • Malignancies
  • Clinical trial